This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216224%3A14310%2F13%3A00069636%21RIV14-MSM-14310___/
n17http://localhost/temp/predkladatel/
n13http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n15http://linked.opendata.cz/resource/domain/vavai/subjekt/
n6http://linked.opendata.cz/ontology/domain/vavai/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/
skoshttp://www.w3.org/2004/02/skos/core#
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n16http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n5http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216224%3A14310%2F13%3A00069636%21RIV14-MSM-14310___
rdf:type
skos:Concept n6:Vysledek
dcterms:description
Primary debulking surgery before adjuvant chemotherapy is the standard of care for patients with advanced ovarian cancer, but neoadjuvant CT is considered to be an alternative therapeutic approach in stage IIIC or IV disease. We evaluated patients with NACT and its influence on radicality of surgery and OS. Primary debulking surgery before adjuvant chemotherapy is the standard of care for patients with advanced ovarian cancer, but neoadjuvant CT is considered to be an alternative therapeutic approach in stage IIIC or IV disease. We evaluated patients with NACT and its influence on radicality of surgery and OS.
dcterms:title
Neoadjuvant chemotherapy for primary advanced ovarian cancer Neoadjuvant chemotherapy for primary advanced ovarian cancer
skos:prefLabel
Neoadjuvant chemotherapy for primary advanced ovarian cancer Neoadjuvant chemotherapy for primary advanced ovarian cancer
skos:notation
RIV/00216224:14310/13:00069636!RIV14-MSM-14310___
n6:predkladatel
n15:orjk%3A14310
n4:aktivita
n16:S
n4:aktivity
S
n4:dodaniDat
n5:2014
n4:domaciTvurceVysledku
n13:3062023 n13:5407656
n4:druhVysledku
n11:O
n4:duvernostUdaju
n8:S
n4:entitaPredkladatele
n14:predkladatel
n4:idSjednocenehoVysledku
91318
n4:idVysledku
RIV/00216224:14310/13:00069636
n4:jazykVysledku
n9:eng
n4:klicovaSlova
neoadjuvant chemotherapy; ovarian cancer
n4:klicoveSlovo
n10:neoadjuvant%20chemotherapy n10:ovarian%20cancer
n4:kontrolniKodProRIV
[9ADCBB305D9C]
n4:obor
n12:BB
n4:pocetDomacichTvurcuVysledku
2
n4:pocetTvurcuVysledku
8
n4:rokUplatneniVysledku
n5:2013
n4:tvurceVysledku
Bartoš, P. Šupíková, P. Horová, Ivanka Vopatová, Kamila Těžká, M. Soumarová, Renata Trhlík, M. Koláček, Jan
n17:organizacniJednotka
14310